SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lupin - Quaterly Results

06 Aug 2024 Evaluate
The Revenue for the quarter ended  June 2024 of Rs. 41676.30 millions grew by 19.22 % from Rs. 34956.40 millions.The Profit  for the quarter ended June 2024 of  Rs. 8891.80  millions  grew by 86.43% from Rs. 4769.60 millions.Operating profit surged to 12378.90 millions from the corresponding previous quarter of 7327.60 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 41676.30 34956.40 19.22 41676.30 34956.40 19.22 146665.00 112588.30 30.27
Other Income 390.80 277.40 40.88 390.80 277.40 40.88 1067.30 912.60 16.95
PBIDT 12378.90 7327.60 68.94 12378.90 7327.60 68.94 35657.90 11739.20 203.75
Interest 135.50 161.80 -16.25 135.50 161.80 -16.25 563.50 984.40 -42.76
PBDT 12243.40 7165.80 70.86 12243.40 7165.80 70.86 35094.40 10754.80 226.31
Depreciation 1414.20 1400.50 0.98 1414.20 1400.50 0.98 7247.50 5483.40 32.17
PBT 10829.20 5765.30 87.83 10829.20 5765.30 87.83 27846.90 5271.40 428.26
TAX 1937.40 995.70 94.58 1937.40 995.70 94.58 4586.00 1019.30 349.92
Deferred Tax 45.50 -11.50 -495.65 45.50 -11.50 -495.65 -254.50 60.40 -521.36
PAT 8891.80 4769.60 86.43 8891.80 4769.60 86.43 23260.90 4252.10 447.04
Equity 911.90 910.20 0.19 911.90 910.20 0.19 911.40 910.00 0.15
PBIDTM(%) 29.70 20.96 41.70 29.70 20.96 41.70 24.31 10.43 133.18

Lupin Share Price

2245.65 -132.25 (-5.56%)
11-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.40
Dr. Reddys Lab 1279.70
Cipla 1304.70
Zydus Lifesciences 956.65
Lupin 2245.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×